Redhill Biopharma Ltd. (RDHL): Price and Financial Metrics

Redhill Biopharma Ltd. (RDHL)

Today's Latest Price: $8.82 USD

0.19 (2.20%)

Updated Dec 4 4:00pm

Add RDHL to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 240 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

RDHL Stock Summary

  • The ratio of debt to operating expenses for RedHill Biopharma Ltd is higher than it is for about just 10.21% of US stocks.
  • With a price/sales ratio of 49.45, RedHill Biopharma Ltd has a higher such ratio than 95.32% of stocks in our set.
  • Revenue growth over the past 12 months for RedHill Biopharma Ltd comes in at 209,600%, a number that bests 99.96% of the US stocks we're tracking.
  • Stocks with similar financial metrics, market capitalization, and price volatility to RedHill Biopharma Ltd are VHC, URGN, SLGL, ZLAB, and MDWD.
  • Visit RDHL's SEC page to see the company's official filings. To visit the company's web site, go to

RDHL Stock Price Chart Interactive Chart >

Price chart for RDHL

RDHL Price/Volume Stats

Current price $8.82 52-week high $11.35
Prev. close $8.63 52-week low $3.26
Day low $8.60 Volume 105,900
Day high $8.88 Avg. volume 353,977
50-day MA $9.15 Dividend yield N/A
200-day MA $7.45 Market Cap 329.95M

Redhill Biopharma Ltd. (RDHL) Company Bio

RedHill Biopharma Ltd. focuses on the development and acquisition of late clinical-stage, proprietary, and orally-administered drugs for the treatment of inflammatory and gastrointestinal diseases, including gastrointestinal cancers in Israel. The company was founded in 2009 and is based in Tel Aviv, Israel.

RDHL Latest News Stream

Event/Time News Detail
Loading, please wait...

RDHL Latest Social Stream

Loading social stream, please wait...

View Full RDHL Social Stream

Latest RDHL News From Around the Web

Below are the latest news stories about RedHill Biopharma Ltd that investors may wish to consider to help them evaluate RDHL as an investment opportunity.

The Daily Biotech Pulse: Moderna Inks 2 R&D Deals, BioNTech To Buy Manufacturing Facility, Dyne Therapeutics IPO

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 16) Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ) (the first subject has been dosed in a Phase 3 trial evaluating etrasimod for the potential treatment of moderately to severely active ulcerative colitis) Beigene Ltd (NASDAQ: BGNE ) BioLife Solutions Inc (NASDAQ: BLFS ) Checkpoint Therapeutics Inc (NASDAQ: CKPT ) Denali Therapeutics Inc (NASDAQ: DNLI ) Dr.Reddy's Laboratories Ltd (NYSE: RDY ) (announced a deal with Russia for 100 million doses of Sputnik-V vaccine against the coronavirus) Fortress Biotech (NASDAQ: FBIO ) Guardant Health Inc (NASDAQ: GH ) Immunovant Inc (NASDAQ: IMVT ) Insmed Incorporated (NASDAQ: INSM ) InVitae Corp (NYSE: NVTA ) ...

Benzinga | September 17, 2020

RedHill: Possibilities Abound

It has been nearly a year since I last checked in on RedHill Biopharma (RDHL). At the time it had just received FDA approval for "Talicia (omeprazole magnesium, amoxicillin and rifabutin) delayed-release capsules 10 mg/250 mg/12.5 mg for the treatment of Helicobacter pylori (H. pylori) infection in adults." The article,...

Out of Ignorance on Seeking Alpha | September 11, 2020

RedHill Biopharma (RDHL) Investor Presentation - Slideshow

The following slide deck was published by RedHill Biopharma Ltd. in conjunction with this event....

SA Transcripts on Seeking Alpha | September 11, 2020

The Daily Biotech Pulse: Positive Readout From Galapagos, Intersect ENT Strikes Distribution Deal, Sol Gel's Regulatory Filing Accepted For Review

Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 10) Agenus Inc (NASDAQ: AGEN ) Akouos Inc (NASDAQ: AKUS ) BioLife Solutions Inc (NASDAQ: BLFS ) Checkpoint Therapeutics Inc (NASDAQ: CKPT ) ESSA Pharma Inc (NASDAQ: EPIX ) Fortress Biotech (NASDAQ: FBIO ) Harmony Biosciences Holdings Inc (NASDAQ: HRMY ) Inspire Medical Systems Inc (NYSE: INSP ) Kintara Therapeutics Inc (NASDAQ: KTRA ) Kura Oncology Inc (NASDAQ: KURA ) Protagonist Therapeutics Inc (NASDAQ: PTGX ) RedHill Biopharma Ltd (NASDAQ: RDHL ) Silk Road Medical Inc (NASDAQ: SILK ) Shockwave Medical Inc (NASDAQ: SWAV ) Trillium Therapeutics Inc (NASDAQ: TRIL ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows Sept. 10) ADiTx Therapeutics Inc (NASDAQ: ADTX ) AnPac Bio-Medical Science Co Ltd – ADR (NASDAQ: ANPC )(reac...

Benzinga | September 11, 2020

RedHill Biopharma Announces Positive Recommendation from Independent Committee to Continue U.S. Phase 2 COVID-19 Study, and Approval of COVID-19 Phase 2/3 Study in Italy

A pre-scheduled independent Safety Monitoring Committee (SMC) has recommended that the U.S. Phase 2 COVID-19 study with opaganib continue with no changes;…

GlobeNewswire | August 27, 2020

Read More 'RDHL' Stories Here

RDHL Price Returns

1-mo 2.68%
3-mo 18.55%
6-mo 29.33%
1-year 35.28%
3-year 84.13%
5-year -31.04%
YTD 45.30%
2019 9.37%
2018 7.98%
2017 -50.86%
2016 -18.79%
2015 -3.38%

Continue Researching RDHL

Want to see what other sources are saying about RedHill Biopharma Ltd's financials and stock price? Try the links below:

RedHill Biopharma Ltd (RDHL) Stock Price | Nasdaq
RedHill Biopharma Ltd (RDHL) Stock Quote, History and News - Yahoo Finance
RedHill Biopharma Ltd (RDHL) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.9098 seconds.